Grufity logo
Grufity logo
AVAH

AVAH - Aveanna Healthcare Holdings Inc. Stock Price, Fair Value and News

$9.49-0.25 (-2.57%)
Delayed as of 22 Jul 2026, 03:01 pm ET

64/100

AVAH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

64/100

AVAH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

AVAH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AVAH Price Action

Last 7 days

4.1%

Last 30 days

24.8%

Last 90 days

50.2%

Trailing 12 Months

141.2%

AVAH RSI Chart

AVAH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AVAH Valuation

Market Cap

2.1B

Price/Earnings (Trailing)

8.11

Price/Sales (Trailing)

0.84

EV/EBITDA

11.3

Price/Free Cashflow

15.28

AVAH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

AVAH Fundamentals

AVAH Revenue

Revenue (TTM)

2.5B

Rev. Growth (Yr)

15.86%

Rev. Growth (Qtr)

-2.2%

AVAH Earnings

Earnings (TTM)

261.5M

Earnings Growth (Yr)

702.1%

Earnings Growth (Qtr)

-76.7%

AVAH Profitability

EBT Margin

5.62%

Return on Equity

108.93%

Return on Assets

12.93%

Free Cashflow Yield

6.55%

AVAH Investor Care

Shares Dilution (1Y)

11.86%

Diluted EPS (TTM)

1.21

AVAH Alerts

  • 3 major insider sales recently.
Revenue & Growth

How Aveanna Healthcare Holdings Inc. generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
20262.5B---
20252.1B2.2B2.3B2.4B
20241.9B2.0B2.0B2.0B
20231.8B1.8B1.9B1.9B
20221.7B1.7B1.8B1.8B
20211.6B1.6B1.7B1.7B
20201.4B1.4B1.5B1.5B
2019---1.4B
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Aveanna Healthcare Holdings Inc.

AVAH
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
 CEO
 WEBSITEaveanna.com
 SECTORHealthcare
 INDUSTRYMedical Care Facilities
 EMPLOYEES33700

Aveanna Healthcare Holdings Inc. Frequently Asked Questions

AVAH is the stock ticker symbol of Aveanna Healthcare Holdings Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Jul 21 2026, market cap of Aveanna Healthcare Holdings Inc. is 2.12 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Tue Jul 21 2026, AVAH's PE ratio (Price to Earnings) is 8.11 and Price to Sales (PS) ratio is 0.84. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AVAH PE ratio will change depending on the future growth rate expectations of investors.